Physician profile
Robert D Rowley
NPI 1750468476
$253.16
in general payments reported to CMS, 2019-2025
10 companies · $108 in 2025
The $108 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32.43 · 2020: $12.95 · 2023: $35.20 · 2024: $64.29 · 2025: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $208.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $207.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $41.63 | 2023-2025 | Cologuard Collection Kit |
| Phadia US INC. | $40.15 | 2024-2025 | Immunocap |
| Lilly USA, LLC | $35.39 | 2019-2024 | Mounjaro |
| Abbott Laboratories | $26.03 | 2025 | Freestyle Libre 3 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.89 | 2025 | Xifaxan |
| Teva Pharmaceuticals USA, INC. | $20.68 | 2019 | |
| Corcept Therapeutics | $19.24 | 2025 | Korlym |
| Pfizer INC. | $16.95 | 2023 | |
| Novo Nordisk INC | $16.25 | 2024 | Ozempic, Rybelsus |
| Allergan, INC. | $12.95 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Rowley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.